The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting scribble

Journal of Virology

Volumn 84, Issue 21, 2010, Pages 11164-11174

  Liu, Hongbing ^a   Golebiewski, Lisa ^a   Dow, Eugene C ^a   Krug, Robert M ^b   Javier, Ronald T ^a   Rice, Andrew P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 1; PDZ PROTEIN; SMALL INTERFERING RNA; INS1 PROTEIN, INFLUENZA VIRUS; MEMBRANE PROTEIN; SCRIB PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; AVIAN INFLUENZA VIRUS; BINDING AFFINITY; CELL PROTECTION; CONTROLLED STUDY; INFLUENZA VIRUS A H3N2; MAMMAL CELL; MOLECULAR MECHANICS; NICK END LABELING; NONHUMAN; PDZ DOMAIN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN TARGETING; VIRUS REPLICATION; ANIMAL; AVIAN INFLUENZA; BINDING SITE; BIRD; CELL LINE; CHEMISTRY; HUMAN; INFLUENZA VIRUS A; PATHOLOGY; PHYSIOLOGY;

AVES; AVIAN INFLUENZA VIRUS; INFLUENZA A VIRUS; MAMMALIA; MUS; ORTHOMYXOVIRIDAE;

ANIMALS; APOPTOSIS; BINDING SITES; BIRDS; CELL LINE; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA IN BIRDS; MEMBRANE PROTEINS; PDZ DOMAINS; TUMOR SUPPRESSOR PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 77957970275     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01278-10     Document Type: Article

References (48)

1. Arpin-Andre, C., and J. M. Mesnard. 2007. The PDZ domain-binding motif of the human T cell leukemia virus type 1 tax protein induces mislocalization of the tumor suppressor hScrib in T cells. J. Biol. Chem. 282:33132-33141.
2. Assemat, E., E. Bazellieres, E. Pallesi-Pocachard, A. Le Bivic, and D. Massey-Harroche. 2008. Polarity complex proteins. Biochim. Biophys. Acta 1778:614-630.
3. Bornholdt, Z. A., and B. V. Prasad. 2006. X-ray structure of influenza virus NS1 effector domain. Nat. Struct. Mol. Biol. 13:559-560.
4. Bornholdt, Z. A., and B. V. Prasad. 2008. X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature 456:985-988.
5. Chen, W., P. A. Calvo, D. Malide, J. Gibbs, U. Schubert, I. Bacik, S. Basta, R. O'Neill, J. Schickli, P. Palese, P. Henklein, J. R. Bennink, and J. W. Yewdell. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7:1306-1312.
6. Chen, Z., Y. Li, and R. M. Krug. 1999. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J. 18:2273-2283.
7. Chung, S. H., R. S. Weiss, K. K. Frese, B. V. Prasad, and R. T. Javier. 2008. Functionally distinct monomers and trimers produced by a viral oncoprotein. Oncogene 27:1412-1420.
8. Franklin, J. L., K. Yoshiura, P. J. Dempsey, G. Bogatcheva, L. Jeyakumar, K. S. Meise, R. S. Pearsall, D. Threadgill, and R. J. Coffey. 2005. Identification of MAGI-3 as a transforming growth factor-alpha tail binding protein. Exp. Cell Res. 303:457-470.
9. Frese, K. K., I. J. Latorre, S. H. Chung, G. Caruana, A. Bernstein, S. N. Jones, L. A. Donehower, M. J. Justice, C. C. Garner, and R. T. Javier. 2006. Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor. EMBO J. 25:1406-1417.
10. Gack, M. U., R. A. Albrecht, T. Urano, K. S. Inn, I. C. Huang, E. Carnero, M. Farzan, S. Inoue, J. U. Jung, and A. Garcia-Sastre. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439-449.
11. Gannage, M., D. Dormann, R. Albrecht, J. Dengjel, T. Torossi, P. C. Ramer, M. Lee, T. Strowig, F. Arrey, G. Conenello, M. Pypaert, J. Andersen, A. Garcia-Sastre, and C. Munz. 2009. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 6:367-380.
12. Glaunsinger, B. A., S. S. Lee, M. Thomas, L. Banks, and R. Javier. 2000. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19:5270-5280.
13. Hale, B. G., D. Jackson, Y. H. Chen, R. A. Lamb, and R. E. Randall. 2006. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol- 3-kinase signaling. Proc. Natl. Acad. Sci. U. S. A. 103:14194-14199.
14. Hale, B. G., R. E. Randall, J. Ortin, and D. Jackson. 2008. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89:10-76.
15. Hatada, E., S. Saito, and R. Fukuda. 1999. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J. Virol. 73:2425-2433. (Pubitemid 29098149)
16. Herrmann, C. H., R. G. Carroll, P. Wei, K. A. Jones, and A. P. Rice. 1998. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J. Virol. 72:9881-9888.
17. Herrmann, C. H., and M. A. Mancini. 2001. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions. J. Cell Sci. 114:1491-1503.
18. Herrmann, C. H., and A. P. Rice. 1993. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197:601-608.
19. Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1612-1620.
20. Hung, A. Y., and M. Sheng. 2002. PDZ domains: structural modules for protein complex assembly. J. Biol. Chem. 277:5699-5702.
21. Jackson, D., M. J. Hossain, D. Hickman, D. R. Perez, and R. A. Lamb. 2008. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc. Natl. Acad. Sci. U. S. A. 105:4381-4386.
22. Javier, R. T. 2008. Cell polarity proteins: common targets for tumorigenic human viruses. Oncogene 27:7031-7046.
23. Korteweg, C., and J. Gu. 2008. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am. J. Pathol. 172:1155-1170.
24. Krug, R. M., W. Yuan, D. L. Noah, and A. G. Latham. 2003. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309:181-189.
25. Latorre, I. J., M. H. Roh, K. K. Frese, R. S. Weiss, B. Margolis, and R. T. Javier. 2005. Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J. Cell Sci. 118:4283-4293.
26. Lee, S. S., B. Glaunsinger, F. Mantovani, L. Banks, and R. T. Javier. 2000. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J. Virol. 74:9680-9693.
27. Liu, J., P. A. Lynch, C. Y. Chien, G. T. Montelione, R. M. Krug, and H. M. Berman. 1997. Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat. Struct. Biol. 4:896-899.
28. Massimi, P., A. Shai, P. Lambert, and L. Banks. 2008. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene. 27:1800-1804. (Pubitemid 351380264)
29. McLaughlin, M., R. Hale, D. Ellston, S. Gaudet, R. A. Lue, and A. Viel. 2002. The distribution and function of alternatively spliced insertions in hDlg. J. Biol. Chem. 277:6406-6412.
30. Min, J. Y., and R. M. Krug. 2006. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. U. S. A. 103:7100-7105.
31. Min, J. Y., S. Li, G. C. Sen, and R. M. Krug. 2007. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363:236-243.
32. Nakagawa, S., and J. M. Huibregtse. 2000. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20:8244-8253.
33. Nemeroff, M. E., S. M. Barabino, Y. Li, W. Keller, and R. M. Krug. 1998. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′ end formation of cellular pre-mRNAs. Mol. Cell 1:991-1000.
34. Nourry, C., S. G. Grant, and J. P. Borg. 2003. PDZ domain proteins: plug and play! Sci. STKE 2003:RE7.
35. Obenauer, J. C., J. Denson, P. K. Mehta, X. Su, S. Mukatira, D. B. Finkelstein, X. Xu, J. Wang, J. Ma, Y. Fan, K. M. Rakestraw, R. G. Webster, E. Hoffmann, S. Krauss, J. Zheng, Z. Zhang, and C. W. Naeve. 2006. Large-scale sequence analysis of avian influenza isolates. Science 311:1576-1580.
36. Pichlmair, A., O. Schulz, C. P. Tan, T. I. Naslund, P. Liljestrom, F. Weber, and C. Reis e Sousa. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997-1001.
37. Rossman, J. S., and R. A. Lamb. 2009. Autophagy, apoptosis, and the influenza virus M2 protein. Cell Host Microbe 6:299-300.
38. Sakurai, A., S. Fukuhara, A. Yamagishi, K. Sako, Y. Kamioka, M. Masuda, Y. Nakaoka, and N. Mochizuki. 2006. MAGI-1 is required for Rap1 activation upon cell-cell contact and for enhancement of vascular endothelial cadherin-mediated cell adhesion. Mol. Biol. Cell 17:966-976.
39. Skelton, N. J., M. F. Koehler, K. Zobel, W. L. Wong, S. Yeh, M. T. Pisabarro, J. P. Yin, L. A. Lasky, and S. S. Sidhu. 2003. Origins of PDZ domain ligand specificity. Structure determination and mutagenesis of the Erbin PDZ domain. J. Biol. Chem. 278:7645-7654.
40. Soubies, S. M., C. Volmer, G. Croville, J. Loupias, B. Peralta, P. Costes, C. Lacroux, J. L. Guerin, and R. Volmer. 2010. Species-specific contribution of the four C-terminal amino acids of influenza A virus NS1 protein to virulence. J. Virol. 84:6733-6747.
41. Spaller, M. R. 2006. Act globally, think locally: systems biology addresses the PDZ domain. ACS Chem. Biol. 1:207-210.
42. Takeda, M., A. Pekosz, K. Shuck, L. H. Pinto, and R. A. Lamb. 2002. Influenza A virus M2 ion channel activity is essential for efficient replication in tissue culture. J. Virol. 76:1391-1399.
43. Takizawa, S., K. Nagasaka, S. Nakagawa, T. Yano, K. Nakagawa, T. Yasugi, T. Takeuchi, T. Kanda, J. M. Huibregtse, T. Akiyama, and Y. Taketani. 2006. Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli. Genes Cells 11:453-464.
44. Thomas, M., R. Laura, K. Hepner, E. Guccione, C. Sawyers, L. Lasky, and L. Banks. 2002. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21:5088-5096.
45. Tonikian, R., Y. Zhang, S. L. Sazinsky, B. Currell, J. H. Yeh, B. Reva, H. A. Held, B. A. Appleton, M. Evangelista, Y. Wu, X. Xin, A. C. Chan, S. Seshagiri, L. A. Lasky, C. Sander, C. Boone, G. D. Bader, and S. S. Sidhu. 2008. A specificity map for the PDZ domain family. PLoS Biol. 6:e239.
46. Werme, K., M. Wigerius, and M. Johansson. 2008. Tick-borne encephalitis virus NS5 associates with membrane protein scribble and impairs interferon-stimulated JAK-STAT signalling. Cell Microbiol. 10:696-712. (Pubitemid 351194096)
47. Xu, T., J. Qiao, L. Zhao, G. Wang, G. He, K. Li, Y. Tian, M. Gao, J. Wang, H. Wang, and C. Dong. 2006. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am. J. Respir. Crit. Care Med. 174:1011-1017.
48. Zhan, L., A. Rosenberg, K. C. Bergami, M. Yu, Z. Xuan, A. B. Jaffe, C. Allred, and S. K. Muthuswamy. 2008. Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 135:865-878.